Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-26 @ 3:42 AM
Study NCT ID:
NCT00813059
Status:
UNKNOWN
Last Update Posted:
2012-02-08
First Post:
2008-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy
Sponsor:
Mount Sinai Hospital, Canada
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
None
Primary Completion Date:
2012-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2012-06
Completion Date Type:
ESTIMATED
First Submit Date:
2008-12-19
First Submit QC Date:
None
Study First Post Date:
2008-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-02-06
Last Update Post Date:
2012-02-08
Last Update Post Date Type:
ESTIMATED